SCNI

Scinai Immunotherapeutics
SCNI

Overview Fund Trends Analyst Outlook Journalist POV

11 hedge funds and large institutions have $4.43M invested in Scinai Immunotherapeutics in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more ownership

Funds ownership: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
11
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$525K
2
+$133K

Top Sellers

1
-$1.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$3.33M
2
$525K
3
$232K
4
$157K
5
$133K
6
$23K
7
$8K
8
$8K
9
$6K
10
$2K
11
$1K